Who owns Mediar Therapeutics?

Mediar Therapeutics is currently owned by Sofinnova Partners, through Sofinnova Capital X, since 2021.

When did Sofinnova Partners acquire Mediar Therapeutics?

Sofinnova Partners acquired Mediar Therapeutics in 2021 (active for 5 years).

Home/Companies/Biotech/Mediar Therapeutics

Mediar Therapeutics

Biotech·

US·Active·5yr hold

Mediar Therapeutics is a healthcare / biotech company, headquartered in United States.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Most recent investor

Sofinnova Partners

2 ownership periods

Key facts

HQUnited States

SectorHealthcare / Biotech

US biotech pioneering a new approach to fibrosis treatment by targeting the fibrotic mediators driving disease progression.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings